news aktuell GmbH

GEMA files model action to clarify AI providers‘ remuneration obligations in Europe

Share

GEMA is the first collecting society worldwide to file a lawsuit against a provider of generative artificial intelligence (AI) systems for the unlicensed use of protected musical works. Specifically, it concerns the US company OpenAI, the autogenerative chatbot systems operator. GEMA accuses OpenAI of reproducing protected song lyrics by German authors without having acquired licenses or paid the authors in question. The aim is to prove that OpenAI systematically uses GEMA's repertoire to train its systems.

Credit: Thanakorn Piadaeng/iStock

OpenAI has become the world's leading provider in the field of generative AI and now boasts annual sales over two billion dollars. In 2024, the company is aiming for sales of up to five billion dollars. Its AI-supported language system or chatbot, ChatGPT, was trained with copyrighted texts, including song lyrics from the repertoire of around 95,000 GEMA members. These authors have not yet been paid for the use of their works.

On November 13, 2024, GEMA therefore filed a lawsuit with the Munich Regional Court to enforce its members’ claims against the American parent company, OpenAI, LLC, and against OpenAI Ireland Ltd., the chatbot’s operator in Europe. The lawsuit‘s subject is the chatbot’s unlicensed reproduction of song lyrics. When simple prompts are entered, the chatbot reproduces the original song lyrics with which the system has obviously been trained.

While other internet services pay licensing fees to authors for using their texts, OpenAI systematically makes use of the authors' content, deliberately infringing copyrights. Fair remuneration is circumvented.

Dr. Tobias Holzmüller, CEO of GEMA, says, "Our members‘ songs are not free raw material for generative AI systems providers‘ business models. Anyone who wants to use these songs must acquire a license and remunerate the authors fairly. We have developed a license model for this. We are taking and will always take legal action against unlicensed use."

Numerous well-known German music artists, including Kristina Bach ("Atemlos"), Rolf Zuckowski, Reinhard Mey, Inga Humpe, Thomas Eckert, Ulf Sommer and Peter Plate, as well as their music publishers, support GEMA's lawsuit. Their song lyrics have demonstrably been exploited by the chatbot without remuneration.

Supervisory Board Chairman Dr. Ralf Weigand says, "Last week, we made it clear with GEMA's AI Charter that human creative achievements must not be used as a free template for the offerings of AI providers in a deeply commercial exploitation chain. Likewise, we cannot accept that copyright infringements occur in the output of chatbots. GEMA's lawsuit sends an important signal: the livelihood of us creative professionals is at stake."

GEMA presented a generative AI licensing model at the end of September. The aim is the fair participation of music creators when their works are used in training systems, in the generation of new AI songs or as part of AI-generated music content. In the past, GEMA had already informed AI model and system operators in writing that they must acquire a license to use GEMA works.

GEMA General Counsel Dr. Kai Welp, says, "The new technology presents us with fundamental legal questions that we absolutely must clarify. This is the only way we will succeed in establishing a licensing model on the market that strikes a fair balance between creators‘ and exploiters‘ interests. Our model procedure makes a decisive contribution to this. However, it also shows that we are prepared to enforce the rights to which authors are entitled."

GEMA’s AI Charter calls for a responsible approach to generative AI. It comprises ten core principles, including protection of intellectual property, fair participation of creative professionals in value creation, sustainability, and transparency and responsibility from AI providers.

Note to editors

FAQ on the lawsuit against OpenAI: www.gema.de/ai-lawsuit

GEMA's AI Charter: www.gema.de/ai-charter

Information on the AI licensing model as well as statements, facts and figures on "AI and music" can be found in GEMA's digital AI dossier at www.gema.de/ki

You can find the "AI and music" study (2024) at www.gema.de/ai-study

Contacts

About us

GEMA represents the copyrights of around 95,000 members in Germany (composers, lyricists, music publishers) as well as over two million rights holders from all over the world. It is one of the world's largest authors' societies for musical works.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

HEIDELBERG anticipates a very strong second half to financial year 2024/202513.11.2024 08:06:09 CET | Press Release

Incoming orders after six months above previous year’s level thanks to strong drupa orders High order backlog provides sound basis for projected sales volume in second half of the year, capacities being fully utilized Strong seasonality in financial year, with sales and EBITDA in the first half of the year within expectations Packaging solutions segment remains growth driver Annual forecast confirmed

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain7.11.2024 11:04:10 CET | Press Release

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures per year in the U.S.[2] QUTENZA® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Topline results are expected in Q4 2025 and Averitas Pharma aims to submit a supplemental new drug application (sNDA) for a US label extension in 2026, subject to positive data.

Pioneering women set the stage for Slush at the INNOVEIT Conference in Helsinki5.11.2024 09:55:00 CET | Press Release

The European Institute of Innovation and Technology (EIT) invites you to celebrate women entrepreneurs driving innovation and investment in Europe. The EIT Community will be hosting the INNOVEIT Conference which will feature industry leaders like Inga Grieger, Katarzyna Piasecki and Laura Wirsztel. A pitch session will showcase pioneering women-led ventures shaping the future of technology. Exclusive insights: Conference attendees will gain access to the latest research findings from the study “Women founders in European deep tech startups” by the initiative EIT Supernovas, revealing women’s impact in deep tech and the launch of the new Data Room which enhances visibility for women-led startups and scaleups by connecting them with potential investors.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye